S. Aureus Translocation From Skin and Nose to Periprosthetic Tissues
Condition:   Staphylococcus Aureus Intervention:   Sponsor:   Rothman Institute Orthopaedics Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2020 Category: Research Source Type: clinical trials

First-in-human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors
Conditions:   Solid Tumor, Adult;   FGFR2 Amplification;   FGFR2 Gene Mutation;   FGFR2 Gene Rearrangement;   FGFR2 Gene Translocation;   FGFR2 Gene Activation;   Intrahepatic Cholangiocarcinoma;   Cholangiocarcinoma;   Endometrial Cancer;   Gastric Cancer;   Breast Cancer Intervention:   Drug: RLY-4008 Sponsor:   Relay Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2020 Category: Research Source Type: clinical trials